Pure Global
NCT05516290

Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure

An In Depth Study Investigating Patterns of Patients In Congestive Heart Failure Clinical Trials
Power Life Sciences Inc.·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Congestive Heart Failure
Study type
Observational
Sponsor & location
Primary sponsor
Power Life Sciences Inc.
Timeline & enrollment
Phase
N/A
Start date
Sep 18, 2022
End date
Sep 18, 2024
Enrollment
500 participants
Primary outcome

Number of patient decides to enroll in a congestive heart failure clinical trial,Rate of patients who remain in a congestive heart failure clinical trial to trial completion

Summary

Clinical trial participation has always been substantially skewed toward certain demographic
 groups. However, there has been little study on whether trial qualities impact participation
 in either a positive or negative way. The goal of this research is to identify the
 characteristics that consistently restrict patients' ability to participate in or complete a
 trial in which they were initially interested. This data will be evaluated via a number of
 demographic lenses in order to find trends that could benefit future Congestive Heart Failure
 sufferers.

ICD-10 classifications
Congestive heart failureHeart failureHypertensive heart disease with (congestive) heart failureHypertensive heart and renal disease with (congestive) heart failureHeart failure, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05516290
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05516290 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Congestive Heart Failure. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.